Most Recent Articles by Jessica Martin
Abnormal ratios of omega-6 to omega-3 fatty acids were associated with the presence of bipolar disorder and the severity and duration of major depressive disorder.
Weight loss may result in improved pain, symptom severity, depression, and fibromyalgia scores in patients with obesity.
A combination of selective serotonin reuptake inhibitors and antipsychotics does not lead to further deterioration of metabolic variables; however, metabolic monitoring should be performed.
Patients were found to have improved pressure pain threshold at the patella and the wrist after weight loss associated with bariatric surgery, suggesting bariatric surgery may improve pain sensitization.
Major depressive disorder with atypical features was shown to share genetic factors with obesity-related traits.
More Articles by Jessica Martin
Endocrinology Advisor Articles
- Metformin and PCOS: Improving Menstrual Cycle and Hormone Profiles
- Denosumab May Increase BMD in Women With Primary Hyperparathyroidism
- T2D May Play a Protective Role Against Developing Aortic Diseases
- Reducing Eating Speed May Prevent Obesity in Type 2 Diabetes
- Diabetes Mortality Trends in Adults With Low eGFR, No Albuminuria
- Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease
- SGLT2 Inhibitors Show High Cardiovascular- and Renal-Protective Effects in T2D
- Type 2 Diabetes Insulin Initiation: Predictors Identified
- Two New Diabetes Medications Now Available
- Managing Acute Pain in Patients With Severe Obesity
- Lipid Metabolism Imbalance and Pathophysiology of Bipolar Disease
- Growth and Development Differences During Puberty in Children With T1D
- Expert Reflects on the Crisis of Physician Suicides
- Antidiabetes Treatment Discontinuation Higher in Patients Undergoing Bariatric Surgery
- Risk for Congenital Malformations With Antithyroid Drugs